Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman

CORT Investors with Losses Encouraged to Contact Firm SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending...